Methods for the prevention of adhesion formation and development involve the administration of therapeutic formulations to a patient which include, as active ingredients, IFN-y or IFN-y enhancers. The IFN-y or IFN-y enhancers are preferably administered to fibrosis tissues in a subject prior to an event which induces adhesion formation, such as a surgical event.
申请公布号
WO02072016(A2)
申请公布日期
2002.09.19
申请号
WO2002US07290
申请日期
2002.03.11
申请人
WAYNE STATE UNIVERSITY;DIAMOND, MICHAEL, P.;SAED, GHASSAN, M.